This guideline provides global, evidence-informed recommendations on the use of indicators for assessing a population’s iron status and application of the use of ferritin concentrations for monitoring and evaluating iron interventions. his guideline aims to help WHO Member States and their partners to ...
DESCRIPTION: In April 2017, the U.S. Department of Veterans Affairs (VA) and the U.S. Department of Defense (DoD) approved a joint clinical practice guideline for the management of type 2 diabetes mellitus. METHODS: The VA/DoD Evidence-Based Practice Work Group convened a joint VA/DoD guideline developme...
DESCRIPTION: In April 2017, the U.S. Department of Veterans Affairs (VA) and the U.S. Department of Defense (DoD) approved a joint clinical practice guideline for the management of type 2 diabetes mellitus. METHODS: The VA/DoD Evidence-Based Practice Work Group convened a joint VA/DoD guideline developme...
Diabète de type 2,
Diabète,
Marqueurs biologiques/sang,
Glycémie/métabolisme,
Angiopathies diabétiques/prévention et contrôle,
Fructosamine/sang,
Hémoglobine glyquée/métabolisme,
Hypoglycémiants/usage thérapeutique,
Espérance de vie,
Préférence des patients,
Soins centrés sur le patient,
Hémoglobine glyquée,
Hypoglycémiants
La Guía de Práctica Clínica (GPC) tiene como misión elaborar recomendaciones que sirvan de ayuda a los profesionales sanitarios del Sistema Nacional de Salud (SNS) en la toma de decisiones para el manejo de los lípidos como factor de Riesgo Cardiovascular. En esta GPC no se abordan los siguientes as...
Maladies cardiovasculaires/étiologie,
Régime alimentaire/effets indésirables,
Hydrates de carbone alimentaires/administration et posologie,
Métabolisme lipidique/physiologie,
Maladies cardiovasculaires/sang,
Inhibiteurs de l'hydroxyméthylglutaryl-CoA réductase/usage thérapeutique,
Exercice physique/physiologie,
Diabète/étiologie,
Hydrates de carbone alimentaires/effets indésirables,
Matières grasses alimentaires/administration et posologie,
Matières grasses alimentaires/effets indésirables,
Dyslipidémies/étiologie,
Dyslipidémies/métabolisme,
Obésité/complications,
Obésité/prévention et contrôle,
Facteurs de risque,
Approche GRADE,
Lipides/sang,
Marqueurs biologiques/sang
Al-Hameed, F;
Al-Dorzi, H. M;
Shamy, A;
Qadi, A;
Bakhsh, E;
Aboelnazar, E;
Abdelaal, M;
Al Khuwaitir, T;
Al-Moamary, M. S;
Al-Hajjaj, M. S;
Brozek, J;
Schünemann, H;
Mustafa, R;
Falavigna, M.
The diagnosis of deep venous thrombosis (DVT) may be challenging due to the inaccuracy of clinical assessment and diversity of diagnostic tests. On one hand, missed diagnosis may result in life-threatening conditions. On the other hand, unnecessary treatment may lead to serious complications. As a result...
This guideline provides global, evidence-informed recommendations on blood folate concentrations in women of reproductive age for the prevention of neural tube defects in populations. It aims to help Member States and their partners in their efforts to make informed decisions on the appropriate nutrition...
Kantor, PF;
Lougheed, J;
Dancea, A;
McGillion, M;
Barbosa, N;
Chan, C;
Dillenburg, R;
Atallah, J;
Buchholz, H;
Chant-Gambacort, C;
Conway, J;
Gardin, L;
George, K;
Greenway, S;
Human, DG;
Jeewa, A;
Price, JF;
Ross, RD;
Roche, SL;
Ryerson, L;
Soni, R;
Wilson, J;
Wong, K.
Pediatric heart failure (HF) is an important cause of morbidity and mortality in childhood. This article presents guidelines for the recognition, diagnosis, and early medical management of HF in infancy, childhood, and adolescence. The guidelines are intended to assist practitioners in office-based or em...
Antagonistes du récepteur de type 1 de l'angiotensine-II/usage thérapeutique,
Inhibiteurs de l'enzyme de conversion de l'angiotensine,
Marqueurs biologiques/sang,
Cardiotoniques,
Catécholamines/usage thérapeutique,
Diurétiques,
Vasodilatateurs,
Vasopressines,
Cardiopathies congénitales,
Mort subite cardiaque/étiologie,
Défaillance cardiaque,
Myocardite,
Échocardiographie,
Électrocardiographie ambulatoire,
Algorithmes,
Cardiopathies congénitales/diagnostic,
Cardiopathies congénitales/thérapie,
Myocarde/anatomopathologie,
Mort subite cardiaque/prévention et contrôle
